Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Trypsin + bromelain + rutoside is a fixed-dose combination medication with anti-inflammatory, anti-edematous, and analgesic properties. This combination contains two enzymes (trypsin and bromelain) and an antioxidant (rutoside). Trypsin and bromelain work by increasing blood supply to affected areas and stimulating the production of substances that fight pain and inflammation. Rutoside, a flavonoid antioxidant also known as rutin, protects the body from damage by free radicals and further reduces swelling. Clinical trials have demonstrated the effectiveness and safety of this combination in treating edema, inflammation, and facilitating wound healing.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on trypsin + bromelain + rutoside.